Condensed Consolidated Statements of Operations - USD ($) |
12 Months Ended | |
|---|---|---|
Mar. 31, 2020 |
Mar. 31, 2019 |
|
| Operating Expenses: | ||
| Research and development | $ 3,034,152 | $ 1,882,345 |
| General and administration expenses | 2,313,870 | 694,954 |
| Total Operating Expenses | 5,348,022 | 2,577,299 |
| Loss From Operations | (5,348,022) | (2,577,299) |
| Other Income (Expenses): | ||
| Interest income | 28,749 | 39,390 |
| Loss Before Income Taxes | (5,319,273) | (2,537,909) |
| Provision for Income Taxes | 1,600 | 1,589 |
| Net Loss | $ (5,320,873) | $ (2,539,498) |
| Net Loss Per Share: | ||
| Basic and Diluted | $ (0.3) | $ (0.15) |
| Weighted average number of shares used in computing basic and diluted net loss per share: | ||
| Basic and Diluted | 17,864,769 | 16,589,633 |